Found 10 matching trials
Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
PHASE1The Phase I clinical trial is divided into two parts. The first part uses a...
Location
Dayao County Center for Disease Control and Prevention
Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months
PHASE11. Burden: Hand-foot-and-mouth disease (HFMD) characterized by skin rash in...
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
PHASE3This multicenter, randomized, double-blind, controlled Phase III clinical t...
Location
Anhui Provincial Center for Disease Control and Prevention
A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
N/AThe purpose of this follow-up study is to evaluate the two-year efficacy, i...
An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
PHASE3The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Immunogenicity and Safety of Two Different Commercial EV71 Vaccines
PHASE4The purpose of this study is to evaluate the immunogenicity and safety of s...
Location
Rushan City Center for Disease Control and Prevention
Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months
PHASE2The goal of this clinical trial is to evaluate the immunogenicity and safet...
Location
Hunan Provincial Center for Disease Control and Prevention
Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children
NAThe purpose of this study is to evaluate the immunogenicity and safety of a...
Location
Pasteur Institute
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
PHASE4This is an open,observational and follow-up clinical trial based on the cli...
Location
Yun County Center for Disease Control and Prevention
Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine
PHASE3The purpose of this study is to evaluate the immunogenicity and safety of t...